New HIV drug LP-98 passes first safety check in healthy people
NCT ID NCT05933824
First seen Apr 26, 2026 · Last updated May 20, 2026 · Updated 3 times
Summary
This early-stage study tested a single injection of LP-98 in 36 healthy adults to see if it is safe and how the body processes it. The goal was not to treat or prevent HIV, but to gather initial safety data. Participants were closely monitored for side effects and changes in vital signs, lab results, and heart activity.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Henan Provincial Hospital for Infectious Diseases (Zhengzhou Sixth People's Hospital)
Zhengzhou, Henan, 450000, China
Conditions
Explore the condition pages connected to this study.